Cancer

Cancer News and Information - Find the Latest Cancer News Headlines Including Drug Treatments and Medical Studies

Previous1/15/2013 7:59:56 AM - 5/8/2013 4:11:56 PMNextReturn to Sitemap

• News Summary: Gene test may help cancer treatment
• Sleep problems linked to increased prostate cancer risk
• FDA strengthens warnings on tanning beds to reduce cancer risk
• Aveo plunges as FDA recommends against cancer drug
• FDA panel votes against approval of Aveo's kidney cancer drug
• Fertility care would be covered under Calif. bill
• Supplements don't help with prostate cancer: study
• Merck melanoma drug gets breakthrough status
• Exact Sciences cancer test meets goal, but disappoints investors
• Melatonin no help for late-stage cancer weight loss
• Roche clinches EU approval for breast cancer drug Perjeta
• Fight tobacco marketing, boost vaccinations to curb cancer, says report
• Heart risk rises with breast cancer radiation
• UK cost body rejects Novartis breast cancer drug
• Anal cancer may be on the rise in the U.S
• Cutting copays may increase women's cancer screening
• Smokers have worse colon cancer prognosis: study
• Merrimack lung cancer drug fails in one mid-stage trial group
• Roche immune therapy cancer drug shows promise in early study
• Pfizer cancer drug wins special status; shares jump
• Tamiflu and cancer drugs lift Roche above forecasts
• Discuss cancer-reducing drugs with women - panel
• Screening might avert many lung cancer deaths: study
• Insight: Cancer drugs proving worth earlier in testing
• FDA approves Roche drug for late-stage metastatic breast cancer
• Peregrine reports positive results from revised lung cancer trial data
• Cephalon wins US court appeal on cancer drug patents
• Oncolytics lung cancer drug shrinks tumors in 95 percent patients
• Sanofi says Zaltrap approved in Europe for colorectal cancer
• Study: lumpectomy survival rates good for early breast cancer
• Cancer gene mutation linked to earlier menopause
• Exercise tied to better colon cancer survival odds
• Celgene's Abraxane increases survival in pancreatic cancer
• UK cost agency backs drugs for preventing breast cancer

• Gene test may help guide prostate cancer treatment
• Doctors to older, heavy smokers: Get CT screening for lung cancer
• FDA warns shorter name of new Roche cancer drug may cause confusion
• FDA advisers vote against Delcath's cancer therapy
• U.S. FDA panel votes against approval of Aveo's kidney cancer drug
• Earnings Preview: Pfizer to report Q1 results
• Celgene 1Q net income slips on marketing costs
• Galapagos says discovers breast cancer drug candidate
• Facebook, Google tech gurus to design cancer research game
• India board rules against Bayer in cancer drug patent case
• Roche gets EU approval for breast cancer drug Perjeta
• Less-frequent Pap smears may miss cancer precursors
• After breast cancer, high-fat dairy foods raise risk of death
• Study finds no constipation, colon cancer link
• Soy tied to better lung cancer survival among women
• Pfizer gets new rebuff from UK cost body for cancer drug
• Navidea cancer imaging agent may see wider use
• Doctors group questions prostate cancer screening
• Weight loss surgery tied to colon cancer risk
• Study finds no fertility drug, ovarian cancer link
• Some drinking tied to longer life post-breast cancer
• Higher cancer risk after Fukushima nuclear disaster: WHO
• Advanced breast cancer inching up in young women
• FDA approves Roche drug for late-stage breast cancer
• Star-gazing software helps fight breast cancer
• Study says IVF does not increase cancer risk
• UK cost agency says "no" to Novartis blood cancer drug Jakavi
• African-Americans still more likely to die from cancer
• FDA approves generic version of cancer drug Doxil
• Celsion's liver cancer therapy fails to meet late-stage trial goal
• High doses of folic acid don't raise cancer risk: study
• FDA approves new use for Roche's Avastin in colon cancer treatment
• Segregation tied to more lung cancer deaths: study

• Ariad reports $6.4M in 1Q sales of leukemia pill
• Woman accused of faking rape now faces fraud case
• FDA advisers recommend against Delcath's cancer therapy
• FDA panel votes against Aveo's kidney cancer drug
• Pharmacyclics posts bigger 1Q loss on stock costs
• Latin America threatened by mounting cancer epidemic: study
• Minorities wait longer for breast cancer surgery
• Exact Sciences stock drops as cancer test disappoints
• FDA staff say calcitonin salmon cancer risk appears plausible
• Colonoscopy tied to lower risk of advanced cancer
• Silence Therapeutics gets German approval for cancer drug trial
• Aeterna Zentaris to stop late-stage cancer drug trial, shares fall
• India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
• Statins tied to lowered liver cancer risk with hepatitis C
• Record gene haul points to better cancer screening
• Cigarette labels may educate about bladder cancer
• Merrimack lung cancer drug fails goal in one mid-stage trial group
• Lack of evidence on oral cancer screening: panel
• Pfizer breast cancer drug wins "breakthrough" status; shares jump
• Cancer drugs and Tamiflu lift Roche first-quarter sales five percent
• Uterine cancer tied to later colon cancer - study
• Cancer risks higher in worst hit Fukushima area: WHO
• FDA approves Bayer drug for rare gastrointestinal tract cancer
• FDA OKs Roche drug for late-stage metastatic breast cancer
• Peregrine reports revised lung cancer trial data
• No increased cancer risk after IVF: study
• Doctors seek help on cancer treatment from IBM supercomputer
• Sanofi says Zaltrap approved in Europe for bowel cancer
• Vaccine group funds cervical cancer immunizations for poor
• Study supports lumpectomy in early breast cancer
• High doses of folic acid not tied to cancer risk
• Lilly stomach cancer drug extends survival vs placebo
• Skin cancer phone apps aren't very accurate: study